Gemfibrozil

Generic Name
Gemfibrozil
Brand Names
Lopid
Drug Type
Small Molecule
Chemical Formula
C15H22O3
CAS Number
25812-30-0
Unique Ingredient Identifier
Q8X02027X3
Background

Gemfibrozil is a fibric acid agent, similar to clofibrate, used to treat Type IIb, IV, and V hyperlipidemias. Gemfibrozil is not a first line treatment and is prescribed to patients who have not responded adequately to weight loss, diet, exercise, and other medications.

Gemfibrozil was granted FDA approval on 21 December 1981.

Indication

Gemfibrozil is indicated to treat patients with Types IV and V hyperlipidemia who have elevated serum triglycerides (usually above 2000mg/dL), elevated VLDL cholesterol, fasting chylomicrons, are at risk of developing pancreatitis, and do not adequately respond to dietary restrictions. Gemfibrozil is also indicated to reduce the risk of developing coronary h...

Associated Conditions
Coronary Heart Disease (CHD), Fredrickson classification type IV Hyperlipidemia, Fredrickson classification type V Hyperlipidemia
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath